Artal Group S.A. - VOR BIOPHARMA INC ownership

VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 60 filers reported holding VOR BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of VOR BIOPHARMA INC
ValueSharesWeighting
Q3 2023$5,699
-31.4%
2,688,0150.0%0.24%
-5.1%
Q2 2023$8,306
-44.7%
2,688,015
-3.8%
0.26%
-71.2%
Q1 2023$15,025
-21.4%
2,792,805
-2.9%
0.89%
-16.3%
Q4 2022$19,123
-99.1%
2,875,581
+422.8%
1.07%
+1047.3%
Q3 2022$2,189,000
-19.9%
550,0000.0%0.09%
-36.3%
Q2 2022$2,734,000
-17.7%
550,0000.0%0.15%
+5.0%
Q1 2022$3,322,000
-48.0%
550,0000.0%0.14%
-19.7%
Q4 2021$6,391,000
-25.9%
550,0000.0%0.17%
-10.4%
Q3 2021$8,624,000
-15.9%
550,0000.0%0.19%
-7.2%
Q2 2021$10,258,000
-56.7%
550,0000.0%0.21%
-50.4%
Q1 2021$23,705,000550,0000.42%
Other shareholders
VOR BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
5AM Venture Management, LLC 6,361,723$38,425,0008.39%
OUP Management Co., LLC 374,714$2,263,0001.72%
RA Capital Management 11,120,973$67,171,0001.47%
Paradigm Biocapital Advisors LP 894,404$5,402,0001.43%
JOHNSON & JOHNSON 1,074,658$6,491,0001.23%
Sarissa Capital Management LP 707,010$4,270,0000.40%
Artal Group S.A. 550,000$3,322,0000.14%
Woodline Partners LP 1,111,123$6,711,0000.11%
Orbimed Advisors 833,333$5,033,0000.08%
Laurion Capital Management LP 857,308$5,178,0000.06%
View complete list of VOR BIOPHARMA INC shareholders